Aflac/$AFL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aflac

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Ticker

$AFL
Sector

Primary listing

NYSE

Employees

12,694

Aflac Metrics

BasicAdvanced
$58B
24.64
$4.43
0.84
$2.24
2.13%

What the Analysts think about Aflac

Analyst ratings (Buy, Hold, Sell) for Aflac stock.

Bulls say / Bears say

Aflac’s Q2 2025 adjusted EPS was $1.78, beating consensus estimates of $1.70, showing resilient profitability in core operations (Reuters).
U.S. net premiums increased 3.4% year-over-year to $1.5 billion in Q2, reflecting strong demand and effective premium pricing in its main market (Reuters).
The board approved a $0.58 per share Q3 dividend, underscoring strong capital generation and continued commitment to shareholder returns (Reuters).
Total Q2 revenue of $4.2 billion missed the $4.33 billion analyst estimate, signaling possible weakness in overall growth and underwriting performance (Reuters).
Aflac reported net investment losses of $421 million for the quarter, highlighting exposure to market volatility and fluctuating interest rates (Reuters).
Shares fell 2.2% following the earnings announcement, reflecting investor concern over the revenue miss and broader investment pressures (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.

Aflac Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Aflac Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AFL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs